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Abstract
A serotonin catabolite, serotonin O‐sulphate (5‐HT‐SO
4
), is hypothesised to accentuate the 
intensity of serotonin metabolism in the central nervous system (CNS). We hypothesised 
that serotonin O‐sulphate could be quantified in human plasma using modern liquid 
chromatography‐mass spectrometry. To test our hypothesis, we performed a critical lit‐
erature review and a three‐stage trial. First, a suitable liquid chromatography‐mass spec‐
trometry (LC‐MS/MS) method for detection of 5‐HT‐SO
4
 in human plasma samples was 
developed. Second, a pilot phase involving four healthy volunteers was executed. Finally, 
nine healthy volunteers were selected for the main study, where a basal plasma level of 
5‐HT‐SO
4
 was measured before and after serotonergic stimulation of the central nervous 
system. One h after stimulation, six study subjects showed a decrease in 5‐HT‐SO
4
 levels, 
while three subjects showed an increase. This was the first study in which naturally occur‐
ring 5‐HT‐SO
4
 was detected by liquid chromatography–mass spectrometry (LC‐MS/MS) 
in the samples of human plasma obtained from healthy volunteers. The method devel‐
oped was specific to the measurement of 5‐HT‐SO
4
 and opens up new possibilities to 
evaluate minor pathways or serotonin metabolism by minimally invasive methods.
Keywords: serotonin, serotonin O‐sulphate, biomarkers, depression
1. Introduction
For several decades, it is noted that biomarkers are playing an increasingly important role in 
drug discovery and development from target identification and validation to clinical applica‐
tion, thereby making the overall process a more rational approach.
Indisputably, serotonin (5‐HT) plays a significant role in the course of depressive disorders, and 
majority of the drugs developed interferes with this pathway. Therefore, we decided to ascer‐
tain the metabolic processes to find perspective areas of research based on experience gathered 
so far. The most exploited laboratory biomarker methods investigating central nervous system 
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Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
(CNS) processes use the cerebrospinal fluid (CSF) as far as it is site specific and reveals local 
processes. Thus, measurement of indoleamine metabolites in the cerebrospinal fluid (CSF) 
remains an analytical evaluation method of drug efficacy during clinical trials. Nevertheless, 
due to patient’s safety concerns and clinical convenience, a method employing less invasive 
approach is highly appreciated by health care professionals.
Thus, our objective was based on critical literature review approach and practical liquid chro‐
matography‐mass spectrometry (LC‐MS/MS) method implementation to investigate a possi‐
bility to use 5‐HT‐SO
4
 as a potential CNS‐specific serotonin metabolism biomarker based on a 
less invasive laboratory method suitable for clinical and pharmacological studies.
2. Literature evidence related to 5‐HT‐SO
4
 appearance in animal and 
humans
Sulphonate conjugation was first described in 1876 and has since been shown to be a signifi‐
cant pathway in the biotransformation of many neurotransmitters.
During a critical literature review, our special attention was drawn to the final phase of 5‐HT 
degradation by sulphotransferases (SULT) and the end product of biotransformation, 5‐HT‐
SO
4
. We identified 66 papers and excluded 51 papers that did not contain data related to 
5‐HT‐SO
4
. In total, 15 papers were included in the final review with 10 analysed in terms of 
outcomes.
We found that during the last century, a sulphation of serotonin was described by Kishimoto 
and a final product of such biotransformation, serotonin‐O‐sulphate, was found [1]. 
Furthermore, during later years in animal experiments, it was approved that 5‐HT‐SO
4
 is 
the final product of serotonin metabolism which is rapidly excreted from the organism [2, 
3]. Later, a similar compound was found in human urine, cerebrospinal liquor and platelets 
[4–6]. During recent years, some research was done with marine molluscs determining 5‐HT‐
SO
4
 in their nervous system [7, 8]. Findings showed that the serotonin metabolite 5‐HT‐SO
4
 
forms from 5‐HT uptake and metabolism in central ganglia and other structures of nervous 
system but not in haemolymph itself.
Table 1 summarises the evidence related to 5‐HT‐SO
4
 appearance in animals and humans.
As shown in Table 1, 5‐HT‐O‐SO
4
 was intensively investigated by G.M. Tyce during the 1980s 
and 1990s. Initially, a considerable amount of acid‐hydrolysable conjugates of dopamine, nor‐
epinephrine (NE) and 5‐HT were detected in lumbar CSF of normal individuals. The amounts 
of conjugated amines were small in comparison to the amounts of homovanillic acid and 
5‐hydroxyindoleaceticacid [9]. In a further study performed with CSF from humans and ven‐
triculocisternal perfusion of African green monkeys found that the sulphates of NE, dopamine 
and 5‐HT are present in the CSF of laboratory animals and humans. All amines and metabo‐
lites were quantitated by using high‐performance liquid chromatography (HPLC) with elec‐
trochemical detection. The amounts of sulphated amines in human CSF always greatly exceed 
the amounts of the free amines [6]. This gave us a preliminary impression of 5‐HT‐SO
4
 site 
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Date Research name Results Analytical methods applied
2009 Analysis of intact glucuronides and 
sulphates of serotonin, dopamine, 
and their phase I metabolites in 
rat brain microdialysates by liquid 
chromatography‐tandem mass 
spectrometry
The LC‐MS/MS method was 
validated by determining the limits 
of detection and quantitation, 
linearity and repeatability for the 
quantitative analysis of 5‐HT and DA 
and their glucuronides, as well as of 
5‐HIAA, DOPAC and HVA and their 
sulphateconjugates.
LC‐MS/MS
2008 5‐HT and 5‐HT‐SO
4
 but not 
tryptophan or 5‐HIAA levels in 
single feeding neurons track animal 
hunger state
Changes in levels of 5‐HT‐SO
4
 in 
the metacerebral giant neurons of 
Pleurobranchaea californica related 
to feeding were observed
Capillary electrophoresis 
with laser‐induced 
wavelength‐resolved 
fluorescence detection 
(CE‐LIF)
2007 Serotonin catabolism in the central 
and enteric nervous systems of 
rats upon induction of serotonin 
syndrome
Serotonin sulphate showed 
surprisingly large increases in rat 
intestinal tissues after induction of 
serotonin syndrome
Capillary electrophoresis 
with laser‐induced native 
fluorescence detection 
(CE‐LINF)
2004 Systemic serotonin sulphate in 
opisthobranch molluscs
5‐HT‐SO
4
 forms in neural cells. Not 
detected in haemolymph
Capillary electrophoresis 
(CE) system
2003 Serotonin catabolism depends 
upon location of release: 
characterisation of sulphated and 
gamma‐glutamylated serotonin 
metabolites in Aplysia californica
The pathway of serotonin 
inactivation with further formation 
of 5‐HT‐SO
4
 depends upon the 
type of neuronal tissue subjected to 
neurotransmitter incubation
CE‐LIF LC‐MS
1988 Presence of 
phenolsulphotransferase activity 
in microvascular endothelial cells: 
formation of 5‐HT‐O‐sulphate in 
intact cells
Existence of phenolsulphotransferase 
in the endothelial cells and formation 
of 5‐HT‐SO
4
verified
Not available
1986 Amine sulphate formation in the 
central nervous system
Origin of the central nervous system 
of amine sulphates (also 5‐HT‐SO
4
) 
in monkeys and humans observed. 
5‐HT‐SO
4
 was detected in CSF of 
monkeys and humans but not in the 
plasma
High performance liquid 
chromatography (HPLC) 
with electrochemical 
detection
1985 Free and conjugated amines in 
human lumbar cerebrospinal fluid
5‐HT‐SO
4
 was detected in the CSF of 
healthy humans
HPLC with electrochemical 
detection
1983 Exploration of the role of 
phenolsulphotransferase in the 
disposition of serotonin in human 
platelets: implications for a novel 
therapeutic strategy against 
depression
Existence of phenolsulphotransferase 
in the platelets and formation of 5‐
HT‐SO
4
 verified
The assay technique‐ 
purified alveolysin toxin
1966 Isolation of serotonin‐O‐sulphate 
from human urine
5‐HT‐SO
4
 isolated from human urine Ion exchange resins
Table 1. Summary of the evidence found related to 5‐HT‐SO
4
 appearance in animals and humans.
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specificity. At the time of above mentioned studies, 5‐HT‐O‐SO
4
 could not be detected in the 
plasma of untreated monkeys and the concentration of 5‐HT‐O‐SO
4
 in brain perfusates versus 
plasma increased after injection of 5‐HT sulphate. The ratio of amine sulphate in the brain 
versus amine sulphate in plasma was greater for 5‐HT‐O‐SO
4
 than for DA‐O‐sulphate at 60 
and 100 min after injection. Finally, it was concluded that although 5‐HT‐O‐SO
4
 could not be 
detected in the plasma of monkeys or humans under normal conditions, the 5‐HT‐O‐SO
4
 in 
ventriculocisternal perfusates undoubtedly originates in the CNS [6].
This obstacle inspired us to analyse more recent studies selected during review.
Some research was conducted with marine molluscs determining 5‐HT‐O‐SO
4
 in their ner‐
vous system [7, 8].
In one such research done in 2003, incubation of neuronal tissue of Aplysia revealed three 
novel 5‐HT catabolites. Figure 1 summarises the metabolism of 5‐HT found in Aplysia central 
ganglia compared to human.
As seen from Figure 1, there is no difference of 5‐HT‐O‐SO
4
 formation between humans and 
molluscs.
As shown in Table 2, the 5‐HT‐O‐SO
4
 can be detected in CNS and its formation though is 
site specific, and later animal studies confirm detection in periphery. Moreover, as far similar 
sulphotransfares exist in sea molluscs and mammals, an equal process should be theorised 
for humans [10]. Also, literature evidence exists that 5‐HT‐SO
4
 was proposed to be measured 
in the animal urine or plasma which makes it to be relative simply detected by HPLC with 
various detectors [11].
Figure 1. Metabolites of 5‐HT in the marine mollusc Aplysia californica versus humans. The novel metabolites are shown 
for Aplysia californica. Only detailed 5‐HIAA metabolism is shown for humans.
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Summarising the literature review, there is evidence of similarities between human and ani‐
mal metabolic pathways, and as far as there is literature evidence of site‐specific 5‐HT‐SO
4
 
formation in animals, we can extrapolate the same to humans.
We noted that historically used methods assumed highly invasive approach of CSF sample 
collection from human subjects. Therefore, search for a minimally invasive method has signif‐
icant clinical benefit. Moreover, the latest 5‐HT‐SO
4
 research revealed experience with LC‐MS 
application for such a purpose.
3. The latest findings related to 5‐HT‐SO
4
 appearance in humans
The evidence in the scientific literature justifies the decision to employ detection of 5‐HT‐SO
4
 
in clinical practice. As far as there was no literature data particularly on 5‐HT‐SO
4
 detection by 
LC‐MS/MS in the human plasma, we initiated a development of the chromatography method 
based on literature evidence related to detection of similar compounds such as indoleamines 
in the human plasma. The objective concerning analytical procedure was to demonstrate that 
it is suitable for its intended purpose—qualitative detection of 5‐HT‐SO
4
 in the human plasma.
Tandem mass spectrometric analysis (MS/MS) was made in a positive‐ion mode (ESI+). The 
electrospray ionisation of 5‐HT‐SO
4
 was weak. Thus, for the further quantitative analysis, a 
following ion transition was used: (257>>160) + (240>>160).
Trial Quantity 
of trial 
subjects
Species 5‐HT‐O‐SO
4
 
qualified
5‐HT‐O‐SO
4
 
quantified
5‐HT‐O‐SO
4
 
found in 
nervous 
system
5‐HT‐O‐
SO
4
 found 
outside 
nervous 
system
Conclusions
Tyce et al. 
[9]
22 Humans No. defined 
as conjugate 
of 5‐HT
No. defined 
as conjugate 
of 5‐HT
No. defined 
as conjugate 
of 5‐HT
No CSF contains 5‐HT 
conjugate
Tyce et al. 
[6]
12/4 Humans/
animals
Yes Yes Yes No 5‐HT‐O‐SO
4
 originates 
from CNS
Stuart 
et al.  
[7]
N/A Animals Yes No Yes No c 5‐HT‐O‐SO
4
 formation 
is nervous‐system 
specific
Stuart 
et al.  
[8]
11 Animals Yes Yes Yes Yes 5‐HT‐O‐SO
4
 forms 
in the nervous 
system but not in 
haemolymph itself
Uutela 
et al.  
[12]
N/A Animals Yes Yes Yes No 5‐HT‐O‐SO
4
 in rat 
brain microdialysates 
was analysed using 
a direct LC‐MS/MS 
method
Table 2. Summary of trials involving 5‐HT‐O‐SO
4
.
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Specificity of the method was assessed visually by comparing multiple reaction monitor‐
ing (MRM) chromatograms of plasma sample spiked with serotonin O‐sulphate, samples 
of plasma and purified water. As seen in Figure 2, in the plasma‐based calibration stan‐
dard (A) and plasma (B), some 1.79–1.80 min retention time peaks can be observed [13]. 
In the plasma‐based calibration standard and “pure” plasma, some peaks with a retention 
time of 1.79–1.80 min were observed. The purified water samples treated similarly do not 
show such signals (C).This signal might be induced by native content of serotonin sul‐
phate found in plasma samples. Conclusion was reached because in the analytical solution 
made of 5% serum albumin, such a signal was not seen [13]. For the MRM chromatograms, 
the test solution of 5% serum albumin (buffered to pH = 7 in a phosphate buffer) was 
prepared.
The results obtained lead to conclusion that the method developed is specific to the com‐
pound of interest, 5‐HT‐SO
4
.
The results obtained lead to the conclusion that the method developed is specific to the 
compound of interest, 5‐HT‐SO
4
, in samples of human plasma. The linearity of detection 
was evaluated three times in different days by analysing calibration standard solutions of 
5‐HT‐SO
4
 [13].
Figure 2. Chromatograms of 5‐HT‐SO
4
 samples. (A) Plasma standard solution (containing 96 ng/mL of 5‐HT‐SO
4
); (B) 
“pure” plasma sample and (C) water.
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This method resulted in a linear relationship between concentration of the analyte (from 10 to 
225 ng/mL) and a mass spectral signal of 5‐HT‐SO
4
 with a calibration curve correlation coefficient 
of >0.98.
The optimal detection limit of 5‐HT‐SO
4
 in the plasma sample was determined to be 26.5 ng/mL. 
Four different concentrations of 5‐HT‐SO
4
 were used for a recovery testing and the method 
gave correct 5‐HT‐SO
4
 detection results, which were justified by the average level of recovery 
of the analyte at 116 ± 8%. The relatively high interval of recovery can be explained due to the 
matrix effect [13].
The intra‐laboratory accuracy of the method over a 3‐day period was characterised by a stan‐
dard deviation of ± 11.95% [13]. Taking into account above mentioned results, the method 
was concluded to be a suitable technique for measuring 5‐HT‐SO
4
 in human blood samples.
The findings of method development phase led to the decision to perform the first‐in‐humans 
study in order to assess the clinical applicability of the LC‐MS/MS method developed, and the 
studies were designed to quantify intra‐individual results using a cohort of healthy subjects. 
The clinical study had a two‐stage design: a plot study and main Study.
The pilot study confirmed that the peaks with retention time 1.79–1.80 min are detected in the 
samples of plasma of healthy volunteers. These peaks corresponded to the signal of 5‐HT‐SO
4
. 
One study subject was exposed to oral intake of L‐5‐hydroxytryptophan (5‐HTP) containing 
food supplement to observe the influence of serotonergic stimulation to 5‐HT‐SO
4
 level. The 
pilot study proved that the 5‐HT‐SO
4
 could be qualified in plasma samples obtained from 
healthy volunteers. The increase in 5‐HT‐SO
4
 level after serotonergic stimulation was observed. 
Unfortunately, all results were below the detection limit of the method and probably due to 
several matrix‐, method‐, or analyte‐specific reasons.
Our primary interest was to ascertain quantitative differences of basal 5‐HT‐SO
4
 levels, the 
intra‐individual sensitivity of the quantitation as well as detection limit issues obtained in the 
pilot study on a larger number of subjects.
Thus, after measurement of the basal 5‐HT‐SO
4
 levels in nine subjects, all of them were exposed 
to serotonergic stimulation with a food supplement containing 100 mg of 5‐HTP and a second 
blood sample was analysed. In six study subjects, a decrease in 5‐HT‐SO
4
 levels was observed 
1 h after 5‐HTP ingestion. Three subjects, however, showed an increase in 5‐HT‐SO
4
 1 h after 
5‐HTP ingestion. Out of nine study subjects and one pilot subject, an increase in 5‐HT‐SO
4
 1 h 
after 5‐HTP ingestion was observed in three women and one man, respectively. The others—
five men and one woman—showed decrease. A graphical chart of study results is shown in 
Figure 3.
The outcome of our studies is that we developed a liquid chromatography method, which is 
specific to the measurement of 5‐HT‐SO
4
 in the samples of human plasma. It is the first time 
when 5‐HT‐SO
4
 was detected in the plasma obtained from healthy volunteers [14]. The sen‐
sibility of the LC‐MS/MS method to detect intra‐individual changes of the compound in the 
healthy volunteers undergoing supplementation with 5‐HTP was observed, but the majority 
of results were below detection limit [13].
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4. Conclusions and discussion
This chapter ascertains a possibility for 5‐HT‐SO
4
 to be employed as a potential serotonin 
metabolism biomarker based on a less invasive laboratory method. Based on critical literature 
review, 5‐HT‐SO
4
 is identified as a potential 5‐HT metabolism biomarker to be detected by a 
minimally invasive approach in human plasma. The novel LC‐MS/MS method, which is spe‐
cific to the measurement of 5‐HT‐SO
4
 in the human plasma, has been developed [13]. It was 
the first time when 5‐HT‐SO
4
 was detected in the plasma obtained from healthy volunteers 
[13]. However, the clinical applicability of the method was not justified as the majority of 
results were below detection limit of 26.5 ng/mL [13].
Concerns regarding the issue of whether 5‐HT‐SO
4
 we found in the plasma has CNS ori‐
gin or not should be evaluated. It is known that L‐amino acid decarboxylase acts both in 
the periphery and in the CNS which can result with the ingested 5‐HTP being converted 
into serotonin in the periphery of the body too [15], but plasmatic serotonin mostly derived 
from peripheral tissues is primarily metabolised in the liver to 5‐hydroxyindole acetate and 
then excreted in the urine [16, 17]. Regarding 5‐HT locating in the gastrointestinal tract, it 
is known that once serotonin reuptake transporter (SERT) has brought serotonin into the 
epithelial cells, it is metabolised to 5‐HIAA by monoamine oxidase which is localised to all 
intestinal epithelial cells [18]. Alternatively, 5‐HT released into the lamina propria may enter 
the portal vein circulation and be detected either as free serotonin or within platelets (via the 
actions of SERT). As the liver processes the portal circulation, enzymes rapidly degrade the 
Figure 3. A graphical view of studies results.
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free 5‐HT. The monoamine oxidase degrades about one‐third to urine detectable 5‐HIAAn. 
The remaining two‐thirds of serotonin is degraded to the metabolite 5‐HT‐O‐glucuronide. 
It should be noted that 5‐HT taken up by platelets is protected from degradation in the liver 
and enters the general blood circulation [18]. Coincidentally, the only sites of 5‐HT sulpha‐
tion identified in humans are the CNS and enteric nervous systems [6, 19] while enteric 
nervous system 5‐HT‐SO
4
 was found only after induction of serotonin syndrome [19]. Some 
isoforms of SULT have been shown to have sulphate serotonin [20]. Also, findings in sea 
molluscs indicate that metabolism of serotonin with further formation of 5‐HT‐SO
4
 depends 
upon the location of release. Thus, haemolymph 5‐HT‐ SO
4
 most probably originates from 
the nervous system [7, 8]. There is also no doubt about the entrance of ingested 5‐HTP into 
CNS [21]. Also, earlier studies concluded that under normal conditions, the 5‐HT‐O‐SO
4
 
originates from CNS [6]. The most significant finding was that 5‐HT‐O‐SO
4
 freely crosses 
blood‐CSF barrier, so physiological circumstances are not preventing the appearance of 
CNS‐originated 5‐HT‐O‐SO
4
 in the venous blood circulation. Therefore, taking into account 
all aforementioned facts, we are more concerned that 5‐HT‐ SO
4
 detected in the study 
[13] mimics serotonin metabolism in CNS. Future investigations are needed to justify this 
assumption.
The most disputable outcome of our research is the elevation or reduction of 5‐HT‐SO
4
. The 
majority of volunteers from the study phase, six out of nine, had a drop of plasma sulphate 
concentration [12]. Although there is no data available regarding diurnal rhythmicity of 
serotonin sulphate levels in the human plasma, we are not able to confirm whether these 
changes are due to the direct influence of serotonergic stimulation. To investigate the possible 
link to the health status of study subjects with 5‐HT‐SO
4
 level changes, we performed ques‐
tioning. Hamilton depression rating scale results revealed mild depression in four subjects. 
Unfortunately, we cannot make any clinical conclusion related to the correlation between 
symptoms and laboratory findings due to results below the detection limit, but the trend 
seems to be very intriguing.
Nevertheless, in the light of literature data, we tend to explain phenomena observed by sub‐
strate inhibition of SULT 1A3 [22, 23]. It could be concluded that under normal circumstances, 
quantity of serotonin synthesised and metabolised is kept under certain limits [20]. Data 
favouring this is evidence of paradoxical actions of the 5‐HTP on the activity of identified sero‐
tonergic neurons in a simple motor circuit. It was found that more serotonin did not lead to 
more potent swim motoraction, implying that serotonin synthesis must be kept withincertain 
limits for the circuit to function properly. Also, alteration of neurotransmitter synthesis can 
lead to grave consequencesfor the output of neuralnetworks [24]. Described mechanisms could 
be taken into account explaining our results. Thus, we hypothesise that a drop of 5‐HT‐SO
4
 
in plasma would be related to the overproduction of serotonin, leading to inhibition of SULT 
1A3. Elevation of 5‐HT‐SO
4
 was probably a sign of serotonin deficiency, but such an opinion 
also requires further investigation. The latter would correlate with the experiment made in sea 
molluscs when hungry animals had significantly higher levels of serotonin and 5‐HT‐SO
4
 than 
their satiated partners [25]. It remains for future investigations to determine whether serotonin 
sulphate found in plasma has central nervous system origin and the reason for elevated or 
lowered 5‐HT‐SO
4
 levels after serotonergic stimulation [13].
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